KRONOX Lab Sciences to acquire 5,000 sq metre Dahej SEZ chemical plant to expand manufacturing capacity

KRONOX Lab Sciences to acquire 5,000 sq metre Dahej SEZ chemical plant to expand manufacturing capacity

KRONOX Lab Sciences has approved the purchase of a 5,000 sq metre chemical manufacturing plant in Dahej SEZ, with completion targeted within one month, subject to regulatory approvals.

✨ Key Takeaways

KRONOX Lab Sciences Limited has approved the acquisition of a chemical manufacturing plant spanning about 5,000 square metres in the Dahej Special Economic Zone, Gujarat, as it seeks to add manufacturing capacity for business growth.

The board cleared the transaction at its meeting on October 14, 2026. The company will acquire the plant at Z/80, Dahej SEZ, from Axiom Chemicals Private Limited. The transaction is limited to the physical plant and associated asset transfer. KRONOX is not acquiring shares in Axiom Chemicals, nor will it obtain control of the seller.

The planned purchase gives KRONOX access to an operating industrial site in one of Gujarat’s established chemical manufacturing clusters. Dahej SEZ is an important location for chemical and process industries because of its industrial infrastructure, port connectivity and SEZ framework. For KRONOX, acquiring an existing plant could provide a quicker route to capacity expansion than developing an entirely new facility, although the company has not disclosed the plant’s installed capacity, product lines or expected production commencement timeline.

The acquisition will be funded through internal accruals and settled in cash. KRONOX did not disclose the consideration payable for the plant. It said the overall cost would include the cash consideration as well as applicable Taxes, duties, stamp duty, registration charges and other incidental expenses.

Looking for Quality Mid-Cap Growth Opportunities?

Explore DSIJ’s Mid Bridge - a research-driven service focused on fundamentally strong mid-cap companies with robust business models and long-term growth potential.

Download Service Brochure

The absence of a disclosed transaction value limits an immediate assesSMEnt of the purchase’s financial scale or the capital commitment involved. Investors will also need further details on the plant’s condition, manufacturing capabilities, environmental clearances, integration requirements and potential revenue contribution before the strategic impact can be quantified.

KRONOX expects to complete the transaction within one month, subject to the execution of definitive agreements and receipt of the required approvals. These include consent from the Development Commissioner or relevant SEZ authority for the transfer of the unit or land-lease rights. Other approvals may be required from the State Pollution Control Board, Gujarat Industrial Development Corporation or other relevant development authorities.

The company said Axiom Chemicals is engaged in the chemicals business and that the plant being acquired is used for chemical manufacturing. KRONOX has not identified the specific chemicals produced at the facility or indicated whether it plans to retain the existing product mix, repurpose the unit or add new manufacturing lines after the acquisition.

In its disclosure, KRONOX said Axiom Chemicals is not a related party. It added that neither its promoters, promoter group nor group companies have any interest in the seller or the proposed transaction. The deal therefore does not qualify as a related-party transaction, according to the company.

The proposed acquisition is an asset-led expansion rather than a corporate acquisition. This distinction means KRONOX will not inherit shareholding control over Axiom Chemicals, while the transaction’s execution will depend on transferring the relevant plant and land-use or lease rights through the required regulatory process.

The completion timeline will now hinge on approvals, documentation and the transfer process. Further disclosures on consideration, plant capacity and the expected operational contribution would be important in determining how materially the Dahej facility can support KRONOX’s manufacturing expansion.

Disclaimer: The article is for informational purposes only and not investment advice.